Zimbabwe has rejected a substantial American health deal valued at $367m (£272m) spanning five years because of the United States' insistence on sensitive data.
The decision became public after a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official representative has since stated that the United States was seeking health data for scientific study and profit while was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for continued dialogue to secure a agreement agreeable to all parties so the nation's critical HIV programme can be sustained.
Broader Background
This development comes after a comparable case in Kenya, where a high court suspended a related deal with the US following legal challenges were filed about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
As per statements, Sixteen African countries have so far agreed to these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our people if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining structures already established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We are open to ongoing dialogue with our US partners on how subsequent co-operation could be structured in a way that respects the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but recommended that talks must proceed since much of the nation's Aids initiatives were funded by foreign aid.
"Where technical issues exist, including those involving data governance or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
The halted deal emphasises the complex debate between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.